Infant perinatal thrombosis and antiphospholipid antibodies: A review

Lupus

Volumn 16, Issue 8, 2007, Pages 634-641

  Boffa, Marie Claire ^a   Lachassinne, E ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

Arterial thrombosis; Lupus anticoagulant; Neonatal antiphospholipid syndrome; Stroke; Thrombotic risk factor; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CARDIOLIPIN ANTIBODY; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHENOBARBITAL; PHENYTOIN; PHOSPHOLIPID ANTIBODY; PREDNISONE; UROKINASE;

ANTIPHOSPHOLIPID SYNDROME; AORTA THROMBOSIS; ARTERY THROMBOSIS; DISEASE SEVERITY; FETUS HYDROPS; HEMATOMA; HUMAN; INTRAUTERINE GROWTH RETARDATION; KIDNEY VEIN THROMBOSIS; LOADING DRUG DOSE; LOW DRUG DOSE; PERINATAL ASPHYXIA; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SAGITTAL SINUS THROMBOSIS; SEPSIS; STROKE; THROMBOPHILIA;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BIRTH WEIGHT; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; RISK FACTORS; THROMBOSIS;

EID: 34548380472     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307079039     Document Type: Review

References (42)

1. Soulier JP, Boffa MC. Avortements a repetition, thromboses et anticoagulant circulant antithromboplastine. Nouv Presse Med 1980; 9: 859-864.
2. Avcin T, Cimaz R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002; 11: 4-11.
3. Cimaz R, Descloux E. Pediatric antiphospholipid syndrome. Rheum Dis Clin N Am 2006; 32: 553-573.
4. Roddy SM, Giang DW. Antiphospholipid antibodies and stroke in an infant. Pediatrics 1991; 87: 933-935.
5. Finazzi G, Cortelazzo S, Viero P et al. Maternal lupus anticoagulant and fatal neonatal thrombosis. Thromb Haemost 1987; 57: 238.
6. Sheridan-Pereira M, Porreco RP, Hays T et al. Neonatal aortic thrombosis associated with the lupus anticoagulant. Obstet Gynecol 1988; 71: 1016-1018.
7. Silver RK, MacGregor SN, Pasternak JF et al. Fetal stroke associated with elevated maternal anticardiolipin antibodies. Obstet Gynecol 1992; 80: 497-499.
8. Contractor S, Hiatt M, Kosmin M et al. Neonatal thrombosis with anticardiolipin antibody in baby and mother. Am J Perinatol 1992; 9: 409-410.
9. Tabbutt S, Griswold WR, Ogino MT et al. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. J Perinatol 1994; 14: 66-70.
10. Hage ML, Liu R, Marcheschi DG et al. Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report. Prenat Diagn 1994; 14: 873-877.
11. Teyssier G, Gautheron V, Absi L et al. Anticorps anticardiolipine, ischemie cerebrale et hemorragie surrenalienne chez un nouveau-nè. Arch Pediatr 1995; 2: 1086-1088.
12. de Klerk OI, de Vries TW, Sinnige GF. An unusual cause of neonatal seizures in a newborn infant. Pediatrics 1997; 100: E8 (abstract).
13. Navarro F, Dona-Naranjo MA, Villanueva I. Neonatal antiphospholipid syndrome. J Rheumatol 1997; 24: 1240-1241.
14. Akanli LF, Trasi SS, Thuraisamy K et al. Neonatal middle cerebral artery infarction: association with elevated maternal anticardiolipin antibodies. Am J Perinatol 1998; 15: 399-402.
15. Chow G, Mellor D. Neonatal cerebral ischaemia with elevated maternal and infant anticardiolipin antibodies. Dev Med Child Neurol 2000; 42: 412-413.
16. Neves J, Costa E, Branca R, Carrilho I, Barbot J, Barbot, C. The identification of multiple thrombophilic risk factors in an infant with cerebrovascular accident. Rev Neurol 2005; 40: 479-481.
17. Tuohy J, Harrison A. Prenatal transfer of anticardiolipin antibodies associated with fatal neonatal aortic thrombosis. Austr NZ J Obst Gynaecol 2005; 45: 175-176.
18. Soares Rolim AM, Castro M, Santiago MB. Neonatal antiphospholipid syndrome. Lupus 2006; 15: 301-303.
19. Paro-Panjan D, Kitanovski L, Avčin T. Neonatal antiphospholipid syndrome associated with heterozygous methyltetrahydrofolate reductase C677T and prothrombin G20210A gene mutations. Rheumatology 2007; 46: 720-721.
20. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
21. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
22. Chalmers EA. Perinatal stroke - risk factors and management. Br J Haematol 2005; 130: 333-343.
23. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96: 939-943.
24. Deally C, Hancock BJ, Giddins N et al. Primary antiphospholipid syndrome: a cause of catastrophic shunt thrombosis in the newborn. J Cardiovasc Surg (Torino) 1999; 40: 261-264.
25. Golomb MR, MacGregor DL, Domi T et al. Presumed pre- or perinatal arterial ischemic stroke: Risk factors and outcomes. Ann Neurol 2001; 50: 163-168.
26. Ebeling F, Petaja J, Alanko S et al. Infant stroke and β2 glycoprotein 1 antibodies: six cases. Eur J Pediatr 2003; 162: 678-681.
27. Katsarou E, Attilakos A, Fessatou S, Tsapra H, Tzavara V, Dracou C. Anti-beta2-glycoprotein I antibodies and ischemic stroke in a 20-month-old boy. Pediatrics 2003; 112: 188-190.
28. Motta M, Chirico G, Rebaioli CB et al. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Am J Perinatol 2006; 23: 247-251.
29. Zurgil N, Bakimer R, Tincani A et al. Detection of anti-phospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE. Lupus 1993; 2: 233-237.
30. Cohen SB, Goldenberg M, Rabinovici J et al. Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the antiphospholipid syndrome. Hum Reprod 2000; 15: 1170-1172.
31. Boffa MC, Aurousseau MH, Lachassinne E et al. European register of babies born to mothers with antiphospholipid syndrome. Lupus 2004; 13: 713-717.
32. Pollard JK, Scott JR, Branch DW. Outcome of children born to women treated during pregnancy for the antiphospholipid syndrome. Obstet Gynecol 1992; 80: 365-368.
33. Botet F, Romera G, Montagut P et al. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J Perinat Med 1997; 25: 192-196.
34. Ruffatti A, Dalla Barba B, Del Ross T et al. Outcome of fifty-five newborns of antiphospholipid antibody-positive mothers treated with calcium heparin during pregnancy. Clin Exp Rheumatol 1998; 16: 605-610.
35. Brewster JA, Shaw NJ, Farqharson RG. Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J Perinat Med 1999; 27: 183-187.
36. Sammaritano LR, Ng S, Sobel R et al. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum 1997; 40: 1998-2006.
37. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 15;80: 1998-2005.
38. Andrew M, Paes B, Milner R et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-1657.
39. Patel P, Weitz J, Brooker LA, Paes B, Mitchell L, Andrew M. Decreased thrombin activity of fibrin clots prepared in cord plasma compared with adult plasma. Pediatr Res 1996; 39: 826-830.
40. Ling X, Delorme M, Berry L et al. Alpha 2-Macroglobulin remains as important as antithrombin III for thrombin regulation in cord plasma in the presence of endothelial cell surfaces. Pediatr Res 1995; 37: 373-378.
41. Boffa MC. Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker. Haemostasis 1996; 26(Suppl 4): 233-243.
42. Menashi S, Aurousseau MH, Gozin D et al. High levels of circulating thrombomodulin in human foetuses and children. Thromb Haemost 1999; 81: 906-909.